Review: KRAS mutations are influential in driving hepatic metastases and predicting outcome in colorectal cancer Review


Authors: Steele, C. W.; Whittle, T.; Smith, J. J.
Review Title: Review: KRAS mutations are influential in driving hepatic metastases and predicting outcome in colorectal cancer
Abstract: Metastatic colorectal cancer (CRC) is a topic of intense research. KRAS mutations have emerged as aggressive drivers of disease. Here we discuss the role of KRAS mutations in metastatic progression of CRC. We describe how KRAS has become a useful biomarker in metastatic CRC and examine where future trials may look to target KRAS mutant tumors for therapeutic benefit.
Keywords: kras; metastatic; colorectal; cancer
Journal Title: Chinese Clinical Oncology
Volume: 8
Issue: 5
ISSN: 2304-3865
Publisher: AME Publishing Company  
Date Published: 2019-10-01
Start Page: 53
Language: English
DOI: 10.21037/cco.2019.08.16
PUBMED: 31597434
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 November 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jesse Joshua Smith
    217 Smith